Status:
COMPLETED
Effect of Goji Berry Consumption on Biochemical Parameters
Lead Sponsor:
Eastern Mediterranean University
Conditions:
Healthy
Hyperlipidemias
Eligibility:
All Genders
19-50 years
Phase:
NA
Brief Summary
Goji Berry as a functional food have been shown to reduce risk of hyperlipidemia, type 2 diabetes, etc. However, human studies are limited in this area. In this study, it has been aimed to evaluate th...
Detailed Description
Healthy individuals have been divided into control and study groups. Individuals in both group have same characteristics such as age, gender, and body mass index (Control Group: 35 individuals - Study...
Eligibility Criteria
Inclusion
- BMI between 20-25 kg/m²
- Female individuals are not in the period of lactation and menopause,
- Absence of any chronic or acute disease diagnosed by a physician,
- No allergies to Goji Berry
- Not consuming goji berry and similar fruits regularly for the last 1 month.
- Not being in the process of body weight loss
- Not doing strenuous physical activity
- Not taking any medication or antioxidant vitamin support
- Not smoking
- Not consuming alcohol (moderate alcohol consumption)
Exclusion
- Not meeting the criteria for inclusion in the study
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06190587
Start Date
May 15 2022
End Date
October 30 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eastern Mediterranean University
Famagusta, Turkish Republic of Northern Cyprus, Cyprus